TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TXMD TherapeuticsMD

Market Closed 11-15 16:00:00 EST

1.40

-0.06

-4.11%

盘后1.36

-0.04-2.63%

19:39 EST

High1.48	Low1.36	Vol26.83K
Open1.46	D1 Closing1.46	Amplitude8.46%
Mkt Cap16.15M	Tradable Cap13.01M	Total Shares11.53M
T/O38.22K	T/O Rate0.29%	Tradable Shares9.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"TXMD","market":"US","secType":"STK","nameCN":"TherapeuticsMD","latestPrice":1.4,"timestamp":1731704400000,"preClose":1.46,"halted":0,"volume":26830,"hourTrading":{"tag":"盘后","latestPrice":1.3632,"preClose":1.4,"latestTime":"19:39 EST","volume":709,"amount":986.2147,"timestamp":1731717595980},"delay":0,"floatShares":9290670,"shares":11532432,"eps":-0.293037,"marketStatus":"Market Closed","change":-0.06,"latestTime":"11-15 16:00:00 EST","open":1.46,"high":1.4835,"low":1.36,"amount":38220.421615,"amplitude":0.084589,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.293037,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731920400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1366689600000,"exchange":"NASDAQ","adjPreClose":1.46,"preHourTrading":{"tag":"盘前","latestPrice":1.46,"preClose":1.46,"latestTime":"09:01 EST","volume":4,"amount":5.93,"timestamp":1731679308499},"postHourTrading":{"tag":"盘后","latestPrice":1.3632,"preClose":1.4,"latestTime":"19:39 EST","volume":709,"amount":986.2147,"timestamp":1731717595980},"volumeRatio":0.9254787788628377,"impliedVol":3.0207,"impliedVolPercentile":0.8294},"requestUrl":"/m/hq/s/TXMD","defaultTab":"news","newsList":[{"id":"2483531507","title":"TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2483531507","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483531507?lang=en_us&edition=fundamental","pubTime":"2024-11-16 06:32","pubTimestamp":1731709920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 4.11% to $1.40 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.24% to 18,680.12 and Dow Jones Industrial Average  falling 0.70% to 43,444.99.This was the stock's fourth consecutive day of losses.TherapeuticsMD Inc. closed $1.67 short of its 52-week high , which the company achieved on November 20th.The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc.  fell 2.74% to $164.99.Trading volume  eclipsed its 50-day average volume of 14,264.Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2483321074","title":"TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 loss per share (vs US$0.13 loss in 3Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483321074","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483321074?lang=en_us&edition=fundamental","pubTime":"2024-11-15 19:31","pubTimestamp":1731670296,"startTime":"0","endTime":"0","summary":"NasdaqGS:TXMD Earnings and Revenue History November 15th 2024. All figures shown in the chart above are for the trailing 12 month  period. TherapeuticsMD shares are down 3.9% from a week ago.You still need to take note of risks, for example - TherapeuticsMD has   3 warning signs   we think you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/therapeuticsmd-third-quarter-2024-earnings-113136134.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TXMD"],"gpt_icon":0},{"id":"2483869377","title":"TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2483869377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483869377?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:32","pubTimestamp":1731537120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  dropped 0.19% to $1.50 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.11% to 43,958.19 and the NASDAQ Composite Index  falling 0.26% to 19,230.73.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed $1.57 below its 52-week high , which the company reached on November 20th.Despite its losses, the stock outperformed some of its competitors Wednesday, as AbbVie Inc.  fell 0.43% to $170.35.Trading volume  eclipsed its 50-day average volume of 13,586.Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2483043377","title":"TherapeuticsMD Reports Reduced Losses Amid Strategic Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2483043377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483043377?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:48","pubTimestamp":1731473320,"startTime":"0","endTime":"0","summary":"Therapeuticsmd Inc ( ($TXMD) ) has released its Q3 earnings. Here is a breakdown of the information Therapeuticsmd Inc presented to its investors. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-reduced-losses-amid-strategic-shift?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-reduced-losses-amid-strategic-shift?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXMD","BK4007"],"gpt_icon":0},{"id":"2483066157","title":"TherapeuticsMD Q3 EPS $(0.05) Up From $(0.13) YoY, Sales $547.00K Up From $(53.00K) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2483066157","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483066157?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:25","pubTimestamp":1731450349,"startTime":"0","endTime":"0","summary":"TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.05) per share. This is a 61.54 percent increase over losses of $(0.13) per share from the same period last year.  The company reported $547.00 thousand in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41923976/therapeuticsmd-q3-eps-0-05-up-from-0-13-yoy-sales-547-00k-up-from-53-00k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TherapeuticsMD Q3 EPS $(0.05) Up From $(0.13) YoY, Sales $547.00K Up From $(53.00K) YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2483888063","title":"TherapeuticsMD: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2483888063","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483888063?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:32","pubTimestamp":1731447160,"startTime":"0","endTime":"0","summary":"BOCA RATON, Fla.  — BOCA RATON, Fla.  — TherapeuticsMD Inc.  on Tuesday reported a loss of $609,000 in its third quarter.The Boca Raton, Florida-based company said it had a loss of 5 cents per share.The woman's health care product company posted revenue of $547,000 in the period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/therapeuticsmd-q3-earnings-snapshot-213240764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TXMD"],"gpt_icon":0},{"id":"2483393057","title":"TherapeuticsMD Inc: Qtrly Shr Loss From Cont Ops $0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2483393057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483393057?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA4DRNYY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TXMD"],"gpt_icon":0},{"id":"2483052933","title":"TherapeuticsMD Announces Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483052933","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483052933?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445500,"startTime":"0","endTime":"0","summary":"BOCA RATON, Fla., November 12, 2024----TherapeuticsMD, Inc.  , a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2024.License revenue, primarily from the Mayne License Agreement, totaled $547 thousand for the third quarter of 2024, an increase of $600 thousand, compared to $ thousand in license revenue for the third quarter of 2023. The increase is primarily attributable to changes in sales of licensed products. Reported negative license revenue of ($53) thousand in the third quarter of 2023 was due to product sales adjustments reported by our licensees.Total operating expenses for the third quarter of 2024 were $1.4 million, a decrease of $314 thousand, or 18.3%, compared to $1.7 million for the third quarter of 2023. This decrease was due to the further optimization of our business through the reduction of costs following our transition to a royalty-based business.Forward-Looking StatementsThis press rel","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NT_bB11fYr2CeCf0d3MiZQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/4186a963a9c8f5b6748405bf93479f0c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NT_bB11fYr2CeCf0d3MiZQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/4186a963a9c8f5b6748405bf93479f0c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/therapeuticsmd-announces-third-quarter-2024-210500408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TXMD","BK4007"],"gpt_icon":1},{"id":"2482629157","title":"TherapeuticsMD Inc. Stock Remains Steady Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2482629157","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482629157?lang=en_us&edition=fundamental","pubTime":"2024-11-12 06:32","pubTimestamp":1731364320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  were unchanged Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.06% to 19,298.76 and the Dow Jones Industrial Average  rising 0.69% to 44,293.13.TherapeuticsMD Inc. closed $1.55 short of its 52-week high , which the company achieved on November 20th.The stock outperformed some of its competitors Monday, as AbbVie Inc.  fell 12.57% to $174.43.Trading volume  eclipsed its 50-day average volume of 13,266.Data source: Dow Jones Market Data, FactSet. Data compiled November 11, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2481966564","title":"TherapeuticsMD Inc. Stock Remains Steady Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2481966564","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481966564?lang=en_us&edition=fundamental","pubTime":"2024-11-07 06:34","pubTimestamp":1730932440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  were unchanged Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 2.95% to 18,983.47 and the Dow Jones Industrial Average  rising 3.57% to 43,729.93.TherapeuticsMD Inc. closed $1.53 short of its 52-week high , which the company reached on November 20th.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  fell 0.24% to $201.20.Trading volume  eclipsed its 50-day average volume of 12,348.Data source: Dow Jones Market Data, FactSet. Data compiled November 6, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2481566888","title":"TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2481566888","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481566888?lang=en_us&edition=fundamental","pubTime":"2024-11-06 06:33","pubTimestamp":1730845980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slumped 0.65% to $1.54 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.43% to 18,439.17 and the Dow Jones Industrial Average  rising 1.02% to 42,221.88.TherapeuticsMD Inc. closed $1.53 below its 52-week high , which the company achieved on November 20th.The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.  rose 0.60% to $201.68.Trading volume  remained 4,369 below its 50-day average volume of 12,282.Data source: Dow Jones Market Data, FactSet. Data compiled November 5, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2481456659","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2481456659","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481456659?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:32","pubTimestamp":1730759520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  inched 0.06% higher to $1.55 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.33% to 18,179.98 and Dow Jones Industrial Average  falling 0.61% to 41,794.60.TherapeuticsMD Inc. closed $1.52 below its 52-week high , which the company reached on November 20th.The stock outperformed some of its competitors Monday, as AbbVie Inc.  fell 1.51% to $200.47.Trading volume  remained 1,660 below its 50-day average volume of 13,270.Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2480586534","title":"TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2480586534","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480586534?lang=en_us&edition=fundamental","pubTime":"2024-11-02 05:33","pubTimestamp":1730496780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 0.06% to $1.55 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.80% to 18,239.92 and the Dow Jones Industrial Average  rising 0.69% to 42,052.19.TherapeuticsMD Inc. closed $1.52 below its 52-week high , which the company achieved on November 20th.Despite its losses, the stock outperformed some of its competitors Friday, as AbbVie Inc.  fell 0.16% to $203.55.Trading volume  remained 3,829 below its 50-day average volume of 13,261.Data source: Dow Jones Market Data, FactSet. Data compiled November 1, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2480983730","title":"TherapeuticsMD Inc. Stock Remains Steady Thursday, Still Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2480983730","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480983730?lang=en_us&edition=fundamental","pubTime":"2024-11-01 05:32","pubTimestamp":1730410320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  were unchanged Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.76% to 18,095.15 and Dow Jones Industrial Average  falling 0.90% to 41,763.46.TherapeuticsMD Inc. closed $1.52 short of its 52-week high , which the company reached on November 20th.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  rose 1.18% to $203.87.Trading volume  eclipsed its 50-day average volume of 13,562.Data source: Dow Jones Market Data, FactSet. Data compiled October 31, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2479263778","title":"TherapeuticsMD Inc. Stock Rises Tuesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2479263778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479263778?lang=en_us&edition=fundamental","pubTime":"2024-10-30 05:33","pubTimestamp":1730237580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  inched 0.32% higher to $1.57 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.78% to 18,712.75 and the Dow Jones Industrial Average  falling 0.36% to 42,233.05.TherapeuticsMD Inc. closed $1.50 below its 52-week high , which the company reached on November 20th.The stock outperformed some of its competitors Tuesday, as AbbVie Inc.  fell 0.12% to $189.45.Trading volume  eclipsed its 50-day average volume of 13,476.Data source: Dow Jones Market Data, FactSet. Data compiled October 29, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2479546538","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2479546538","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479546538?lang=en_us&edition=fundamental","pubTime":"2024-10-29 05:32","pubTimestamp":1730151120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 1.57% to $1.57 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.26% to 18,567.19 and the Dow Jones Industrial Average  rising 0.65% to 42,387.57.The stock's fall snapped a two-day winning streak.TherapeuticsMD Inc. closed $1.51 short of its 52-week high , which the company reached on November 20th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  rose 0.97% to $189.68.Trading volume  remained 1,367 below its 50-day average volume of 13,425.Data source: Dow Jones Market Data, FactSet. Data compiled October 28, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2478691785","title":"TherapeuticsMD Inc. Stock Rises Thursday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2478691785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478691785?lang=en_us&edition=fundamental","pubTime":"2024-10-25 05:32","pubTimestamp":1729805520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  inched 0.32% higher to $1.58 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.76% to 18,415.49 and the Dow Jones Industrial Average  falling 0.33% to 42,374.36.TherapeuticsMD Inc. closed $1.49 short of its 52-week high , which the company achieved on November 20th.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  rose 0.94% to $189.65.Trading volume  remained 4,908 below its 50-day average volume of 13,479.Data source: Dow Jones Market Data, FactSet. Data compiled October 24, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2477391640","title":"TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2477391640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477391640?lang=en_us&edition=fundamental","pubTime":"2024-10-23 05:33","pubTimestamp":1729632780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  inched 0.32% higher to $1.58 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.18% to 18,573.13 and the Dow Jones Industrial Average  falling 0.02% to 42,924.89.TherapeuticsMD Inc. closed $1.49 short of its 52-week high , which the company achieved on November 20th.The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.  rose 1.19% to $188.76.Trading volume  eclipsed its 50-day average volume of 13,544.Data source: Dow Jones Market Data, FactSet. Data compiled October 22, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2477812771","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2477812771","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477812771?lang=en_us&edition=fundamental","pubTime":"2024-10-22 05:32","pubTimestamp":1729546320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 1.56% to $1.58 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.27% to 18,540.00 and the Dow Jones Industrial Average  falling 0.80% to 42,931.60.TherapeuticsMD Inc. closed $1.50 below its 52-week high , which the company achieved on November 20th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  fell 1.23% to $186.54.Trading volume  remained 3,352 below its 50-day average volume of 13,493.Data source: Dow Jones Market Data, FactSet. Data compiled October 21, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2476977626","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2476977626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476977626?lang=en_us&edition=fundamental","pubTime":"2024-10-17 05:33","pubTimestamp":1729114380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 3.44% to $1.58 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.28% to 18,367.08 and the Dow Jones Industrial Average  rising 0.79% to 43,077.70.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed $1.49 short of its 52-week high , which the company achieved on November 20th.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  fell 0.73% to $190.46.Trading volume  eclipsed its 50-day average volume of 13,077.Data source: Dow Jones Market Data, FactSet. Data compiled October 16, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therapeuticsmd.com","stockEarnings":[{"period":"1week","weight":-0.0789},{"period":"1month","weight":-0.1139},{"period":"3month","weight":-0.1566},{"period":"6month","weight":-0.3694},{"period":"1year","weight":-0.4043},{"period":"ytd","weight":-0.3778}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.028865},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.033479},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.005565},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.0513},{"month":5,"riseRate":0.5,"avgChangeRate":-0.009175},{"month":6,"riseRate":0.583333,"avgChangeRate":0.018393},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.044018},{"month":8,"riseRate":0.5,"avgChangeRate":0.050162},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024766},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.08678},{"month":11,"riseRate":0.583333,"avgChangeRate":0.021766},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.002672}],"exchange":"NASDAQ","name":"TherapeuticsMD","nameEN":"TherapeuticsMD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TherapeuticsMD,TXMD,TherapeuticsMD股票,TherapeuticsMD股票老虎,TherapeuticsMD股票老虎国际,TherapeuticsMD行情,TherapeuticsMD股票行情,TherapeuticsMD股价,TherapeuticsMD股市,TherapeuticsMD股票价格,TherapeuticsMD股票交易,TherapeuticsMD股票购买,TherapeuticsMD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}